Cancer
-
October 26, 2020
Philadelphia Eagles pick VUMC resident to sing national anthem before game
The lifelong Eagles fan closed "The Star-Spangled Banner” with a big smile and the exhortation “Go, Birds!” -
October 20, 2020
Preserving gut mucus architecture
A new method that keeps microbes and gut cells together will be useful for studies of complex host-microbe interactions and for analysis of clinical specimens. -
October 9, 2020
Erlanger Health System and Vanderbilt-Ingram Cancer Center partner in cancer care
Erlanger Health System and Vanderbilt University Medical Center, on behalf of Vanderbilt-Ingram Cancer Center (VICC), have entered into a professional service agreement designing a long-term collaboration in comprehensive cancer care, including VICC hematology-oncology services at Erlanger Oncology and Hematology and infusion locations. -
September 29, 2020
VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers. -
September 24, 2020
VICC leading first global study of MDS/MPN overlap syndrome
Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). -
September 17, 2020
Chic Awearness Sept. 24 virtual event to focus on ovarian cancer research
Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19. -
September 17, 2020
New predictors of prostate cancer risk
An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.